neostigmine has been researched along with Colonic Pseudo-Obstruction in 89 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Colonic Pseudo-Obstruction: Functional obstruction of the COLON leading to MEGACOLON in the absence of obvious COLONIC DISEASES or mechanical obstruction. When this condition is acquired, acute, and coexisting with another medical condition (trauma, surgery, serious injuries or illness, or medication), it is called Ogilvie's syndrome.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Critical illness-related colonic ileus (CIRCI) is characterized by the non-passage of stools in critically ill patients as a result of the absence of prokinetic movements of the colon, while the upper gastrointestinal tract functions properly and mechanical ileus is absent: We investigated whether neostigmine resulted in defecation in patients with CIRCI." | 9.09 | Neostigmine resolves critical illness-related colonic ileus in intensive care patients with multiple organ failure--a prospective, double-blind, placebo-controlled trial. ( Bosman, RJ; Oudemans-van Straaten, HM; Stoutenbeek, CP; van der Spoel, JI; Zandstra, DF, 2001) |
| " infusion of neostigmine in patients with acute colonic pseudo-obstruction, which was defined as colonic distention with a cecal diameter of at least 10 cm on plain radiographs and no radiographic evidence of mechanical obstruction." | 9.09 | Neostigmine infusion: new standard of care for acute colonic pseudo-obstruction? ( Amaro, R; Rogers, AI, 2000) |
| "In patients with acute colonic pseudo-obstruction who have not had a response to conservative therapy, treatment with neostigmine rapidly decompresses the colon." | 9.09 | Neostigmine for the treatment of acute colonic pseudo-obstruction. ( Kimmey, MB; Ponec, RJ; Saunders, MD, 1999) |
| " In [patients with acute colonic pseudo-obstruction] is [neostigmine] superior to [conservative treatment] with respect to [duration of symptoms and complications]." | 8.88 | Does neostigmine improve time to resolution of symptoms in acute colonic pseudo-obstruction? ( Habib, NA; Jiao, LR; Kayani, B; Spalding, DR; Zacharakis, E, 2012) |
| "To review the literature on the safety and effectiveness of neostigmine for the treatment of postoperative acute colonic pseudo-obstruction." | 8.88 | Intravenous neostigmine for postoperative acute colonic pseudo-obstruction. ( Elsner, JL; Ensor, CR; Smith, JM, 2012) |
| "Neostigmine (NEO) and decompressive colonoscopy (COL) are two efficacious treatment modalities for acute colonic pseudo-obstruction (ACPO)." | 8.31 | Acute Colonic Pseudo-obstruction: Colonoscopy Versus Neostigmine First? ( Butts, CA; Geng, TA; Muller, A; Ong, AW; Williamson, S, 2023) |
| " We report the case of a critically ill patient with ACPO who experienced bradycardia and a brief episode of asystole when receiving concomitant dexmedetomidine and neostigmine infusions but who later remained hemodynamically stable when receiving propofol and neostigmine infusions." | 8.12 | Asystole Following Concomitant Intravenous Administration of Neostigmine and Dexmedetomidine in a Patient With Acute Colonic Pseudo-Obstruction. ( Bell, CM; Parli, SE; Procter, LD, 2022) |
| "To compare clinical response of intermittent bolus versus continuous infusion neostigmine for acute colonic pseudo-obstruction (ACPO)." | 7.96 | Safety and Efficacy of Intermittent Bolus and Continuous Infusion Neostigmine for Acute Colonic Pseudo-Obstruction. ( Barthol, CA; Foster, DB; Gutierrez, GC; Hall, R; Smedley, LW, 2020) |
| "When conservative methods fail, neostigmine is recommended in the pharmacological treatment of acute colonic pseudo-obstruction (ACPO)." | 7.91 | Neostigmine treatment protocols applied in acute colonic pseudo-obstruction disease: A retrospective comparative study. ( Baş, MA; Çelik, JB; Çiçekçi, F; Duman, A; İlban, Ö, 2019) |
| "Intravenous neostigmine is a well-established treatment for acute colonic pseudo-obstruction (ACPO)." | 7.91 | Subcutaneous neostigmine appears safe and effective for acute colonic pseudo-obstruction (Ogilvie's syndrome). ( Frankel, A; Gillespie, C; Hewett, P; Lu, CT; Wattchow, D, 2019) |
| "Neostigmine is traditionally administered intravenously for treatment of acute colonic pseudo-obstruction (ACPO), though use is associated with administration constraints and adverse effects." | 7.88 | Efficacy and Safety of Subcutaneous Neostigmine for Ileus, Acute Colonic Pseudo-obstruction, or Refractory Constipation. ( Campbell, ME; Grant, M; Greenland, M; Kram, B; Sommer, C; Wells, C, 2018) |
| "Neostigmine can successfully decompress patients with acute colonic pseudo-obstruction (ACPO) who are unresponsive to conservative therapy." | 7.83 | Effective and Safe Use of Neostigmine in Treatment of Acute Kidney Injury Associated with Colonic Pseudo-obstruction after Cardiac Surgery. ( Min, YW; Pyo, JH; Rhee, PL, 2016) |
| "To evaluate predictors of neostigmine response in patients with acute colonic pseudo-obstruction." | 7.73 | Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo-obstruction: a prospective study. ( Balakrishnan, V; John, A; Mehta, R; Mustafa, CP; Nair, P; Raj, VV; Suvarna, D, 2006) |
| "Neostigmine is a simple, safe, and effective therapy for treatment of colonic pseudo-obstruction." | 7.70 | Treatment of acute colonic pseudo-obstruction with neostigmine. ( Freund, U; Mayo, A; Neufeld, D; Paran, H; Shwartz, I; Silverberg, D, 2000) |
| "Twenty-eight patients at Fletcher Allen Health Care and The Cleveland Clinic Foundation were treated for acute colonic pseudo-obstruction with neostigmine 2." | 7.70 | Neostigmine: safe and effective treatment for acute colonic pseudo-obstruction. ( Church, JM; Hyman, NH; Trevisani, GT, 2000) |
| "Sickle cell disease is a disorder that produces significant morbidity and mortality." | 5.35 | Acute colonic pseudoobstruction in a child with sickle cell disease treated with neostigmine. ( Khosla, A; Ponsky, TA, 2008) |
| "Neostigmine is a treatment option for colonic pseudoobstruction." | 5.34 | Use of neostigmine to relieve a suspected colonic pseudoobstruction in pregnancy. ( Rausch, ME; Rosen, T; Troiano, NH, 2007) |
| "Constipation is a common complication of amyotrophic lateral sclerosis (ALS), especially as the disease progresses." | 5.33 | Neostigmine: an alternative treatment for constipation. ( Fu, A, 2005) |
| "Acute colonic pseudo-obstruction (ie, Ogilvie's syndrome) is an uncommon but serious condition in the pediatric population." | 5.31 | Neostigmine for the treatment of pediatric acute colonic pseudo-obstruction. ( Gmora, S; Poenaru, D; Tsai, E, 2002) |
| "Acute colonic pseudoobstruction (ACPO) most commonly develops after surgery, with narcotic administration, or in association with severe illness." | 5.31 | Assessment of predictors of response to neostigmine for acute colonic pseudo-obstruction. ( Baron, TH; Harewood, GC; Loftus, CG, 2002) |
| " NSM is a simple, safe, and effective treatment for ACPO and based on result comparison of this study and previous studies both bolus and slow infusion dosing practices of NSM are effective." | 5.31 | Retrospective study of neostigmine for the treatment of acute colonic pseudo-obstruction. ( Abeyta, BJ; Albrecht, RM; Schermer, CR, 2001) |
| "In patients with acute colonic pseudo-obstruction who have not had a response to conservative therapy, treatment with neostigmine rapidly decompresses the colon." | 5.09 | Neostigmine for the treatment of acute colonic pseudo-obstruction. ( Kimmey, MB; Ponec, RJ; Saunders, MD, 1999) |
| " infusion of neostigmine in patients with acute colonic pseudo-obstruction, which was defined as colonic distention with a cecal diameter of at least 10 cm on plain radiographs and no radiographic evidence of mechanical obstruction." | 5.09 | Neostigmine infusion: new standard of care for acute colonic pseudo-obstruction? ( Amaro, R; Rogers, AI, 2000) |
| "Critical illness-related colonic ileus (CIRCI) is characterized by the non-passage of stools in critically ill patients as a result of the absence of prokinetic movements of the colon, while the upper gastrointestinal tract functions properly and mechanical ileus is absent: We investigated whether neostigmine resulted in defecation in patients with CIRCI." | 5.09 | Neostigmine resolves critical illness-related colonic ileus in intensive care patients with multiple organ failure--a prospective, double-blind, placebo-controlled trial. ( Bosman, RJ; Oudemans-van Straaten, HM; Stoutenbeek, CP; van der Spoel, JI; Zandstra, DF, 2001) |
| "To review the literature on the safety and effectiveness of neostigmine for the treatment of postoperative acute colonic pseudo-obstruction." | 4.88 | Intravenous neostigmine for postoperative acute colonic pseudo-obstruction. ( Elsner, JL; Ensor, CR; Smith, JM, 2012) |
| " In [patients with acute colonic pseudo-obstruction] is [neostigmine] superior to [conservative treatment] with respect to [duration of symptoms and complications]." | 4.88 | Does neostigmine improve time to resolution of symptoms in acute colonic pseudo-obstruction? ( Habib, NA; Jiao, LR; Kayani, B; Spalding, DR; Zacharakis, E, 2012) |
| "Neostigmine (NEO) and decompressive colonoscopy (COL) are two efficacious treatment modalities for acute colonic pseudo-obstruction (ACPO)." | 4.31 | Acute Colonic Pseudo-obstruction: Colonoscopy Versus Neostigmine First? ( Butts, CA; Geng, TA; Muller, A; Ong, AW; Williamson, S, 2023) |
| " We report the case of a critically ill patient with ACPO who experienced bradycardia and a brief episode of asystole when receiving concomitant dexmedetomidine and neostigmine infusions but who later remained hemodynamically stable when receiving propofol and neostigmine infusions." | 4.12 | Asystole Following Concomitant Intravenous Administration of Neostigmine and Dexmedetomidine in a Patient With Acute Colonic Pseudo-Obstruction. ( Bell, CM; Parli, SE; Procter, LD, 2022) |
| "To compare clinical response of intermittent bolus versus continuous infusion neostigmine for acute colonic pseudo-obstruction (ACPO)." | 3.96 | Safety and Efficacy of Intermittent Bolus and Continuous Infusion Neostigmine for Acute Colonic Pseudo-Obstruction. ( Barthol, CA; Foster, DB; Gutierrez, GC; Hall, R; Smedley, LW, 2020) |
| "When conservative methods fail, neostigmine is recommended in the pharmacological treatment of acute colonic pseudo-obstruction (ACPO)." | 3.91 | Neostigmine treatment protocols applied in acute colonic pseudo-obstruction disease: A retrospective comparative study. ( Baş, MA; Çelik, JB; Çiçekçi, F; Duman, A; İlban, Ö, 2019) |
| "Intravenous neostigmine is a well-established treatment for acute colonic pseudo-obstruction (ACPO)." | 3.91 | Subcutaneous neostigmine appears safe and effective for acute colonic pseudo-obstruction (Ogilvie's syndrome). ( Frankel, A; Gillespie, C; Hewett, P; Lu, CT; Wattchow, D, 2019) |
| "Neostigmine is traditionally administered intravenously for treatment of acute colonic pseudo-obstruction (ACPO), though use is associated with administration constraints and adverse effects." | 3.88 | Efficacy and Safety of Subcutaneous Neostigmine for Ileus, Acute Colonic Pseudo-obstruction, or Refractory Constipation. ( Campbell, ME; Grant, M; Greenland, M; Kram, B; Sommer, C; Wells, C, 2018) |
| "Neostigmine can successfully decompress patients with acute colonic pseudo-obstruction (ACPO) who are unresponsive to conservative therapy." | 3.83 | Effective and Safe Use of Neostigmine in Treatment of Acute Kidney Injury Associated with Colonic Pseudo-obstruction after Cardiac Surgery. ( Min, YW; Pyo, JH; Rhee, PL, 2016) |
| "Clozapine is an antipsychotic drug which is used in the treatment of therapy-resistant schizophrenia." | 3.75 | [Ogilvie Syndrome induced by clozapine]. ( Bac, DJ; de Bruin, GJ; van der Klooster, JM; van Puijenbroek, EP, 2009) |
| "To evaluate predictors of neostigmine response in patients with acute colonic pseudo-obstruction." | 3.73 | Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo-obstruction: a prospective study. ( Balakrishnan, V; John, A; Mehta, R; Mustafa, CP; Nair, P; Raj, VV; Suvarna, D, 2006) |
| "Twenty-eight patients at Fletcher Allen Health Care and The Cleveland Clinic Foundation were treated for acute colonic pseudo-obstruction with neostigmine 2." | 3.70 | Neostigmine: safe and effective treatment for acute colonic pseudo-obstruction. ( Church, JM; Hyman, NH; Trevisani, GT, 2000) |
| "Neostigmine is a simple, safe, and effective therapy for treatment of colonic pseudo-obstruction." | 3.70 | Treatment of acute colonic pseudo-obstruction with neostigmine. ( Freund, U; Mayo, A; Neufeld, D; Paran, H; Shwartz, I; Silverberg, D, 2000) |
| "Our aim was to assess the value of a parasympathomimetic drug (neostigmine) in the early resolution of acute colonic pseudo-obstruction (Ogilvie's syndrome)." | 3.69 | Early resolution of Ogilvie's syndrome with intravenous neostigmine: a simple, effective treatment. ( Calvo-Serrano, M; De Fuenmayor, ML; De Tomás, J; Del Valle-Hernández, E; Muñoz-Jiménez, F; Pérez-Díaz, D; Quintans-Rodríguez, A; Turégano-Fuentes, F, 1997) |
| "Administration of PEG in patients with Ogilvie's syndrome after initial resolution of colonic dilation may increase the sustained response rate after initial therapeutic intervention." | 2.72 | Effect of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudo obstruction after resolution of colonic dilation: a prospective, randomised, placebo controlled trial. ( Avgerinos, A; Bergele, C; Mantides, A; Nastos, H; Sgouros, SN; Stefanidis, G; Vassiliadis, K; Vlachogiannakos, J, 2006) |
| "Acute colonic pseudoobstruction (ACPO) is a clinical condition of acute large bowel obstruction without mechanical blockage." | 2.42 | Acute colonic pseudoobstruction. ( Saunders, MD, 2004) |
| "Acute colonic pseudo-obstruction (Ogilvie's syndrome) can be defined as a clinical condition with symptoms, signs and radiological appearance of acute large bowel obstruction unrelated to any mechanical cause." | 2.41 | Review article: the pharmacological treatment of acute colonic pseudo-obstruction. ( Barbara, G; Biagi, G; Cola, B; Corinaldesi, R; De Giorgio, R; De Ponti, F; Stanghellini, V; Tonini, M; Vasina, V, 2001) |
| "Colonic volvulus and acute colonic pseudo-obstruction (ACPO) are 2 causes of benign large-bowel obstruction." | 1.56 | American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the management of acute colonic pseudo-obstruction and colonic volvulus. ( Al-Haddad, M; Buxbaum, JL; Calderwood, AH; Fishman, DS; Fujii-Lau, LL; Jamil, LH; Jue, TL; Khashab, MA; Law, JK; Lee, JK; Naveed, M; Qumseya, BJ; Sawhney, MS; Storm, AC; Thosani, N; Wani, SB, 2020) |
| "Diagnosis of Ogilvie's syndrome is based on clinical and radiologic grounds, and can be treated conservatively or with interventions such as acetylcholinesterase inhibitors (such as neostigmine), decompressive procedures including colonoscopy, and even surgery." | 1.48 | Ogilvie's syndrome: management and outcomes. ( Haj, M; Rockey, DC, 2018) |
| "Neostigmine treatment was required for 1 patient in the intensive care unit setting, and 3 patients were managed conservatively without complications." | 1.46 | The Potentially Fatal Ogilvie's Syndrome in Lateral Transpsoas Access Surgery: A Multi-Institutional Experience with 2930 Patients. ( Beckman, JM; Januszewski, J; Kanter, AS; Keem, SK; Oskuian, RJ; Smith, W; Taylor, W; Uribe, JS, 2017) |
| "Ogilvie's syndrome is a rare and potentially fatal disease that can easily be mistaken for postoperative ileus." | 1.40 | Ogilvie's syndrome after pediatric spinal deformity surgery: successful treatment with neostigmine. ( Hooten, KG; Larson, SD; Oliveria, SF; Pincus, DW, 2014) |
| "Ogilvie syndrome is characterized by dilatation of the large intestine in the absence of mechanical obstruction, usually occurring in adult patients with serious underlying medical conditions and rarely seen in children." | 1.38 | An unusual case of Ogilvie syndrome in a pediatric oncology patient receiving palliative care after failed treatment with neostigmine. ( Baker, JN; Coleman, JL; Johnson, LM; Spraker, HL, 2012) |
| "Here, we report a case of cardiac arrest complicating neostigmine use in a 16-year-old woman with cerebral palsy who was being treated in the intensive care unit after orthopaedic surgery." | 1.37 | Cardiac arrest complicating neostigmine use for bowel opening in a critically ill patient. ( Maher, L; Young, PJ, 2011) |
| "Sickle cell disease is a disorder that produces significant morbidity and mortality." | 1.35 | Acute colonic pseudoobstruction in a child with sickle cell disease treated with neostigmine. ( Khosla, A; Ponsky, TA, 2008) |
| "Neostigmine is a treatment option for colonic pseudoobstruction." | 1.34 | Use of neostigmine to relieve a suspected colonic pseudoobstruction in pregnancy. ( Rausch, ME; Rosen, T; Troiano, NH, 2007) |
| "Constipation is a common complication of amyotrophic lateral sclerosis (ALS), especially as the disease progresses." | 1.33 | Neostigmine: an alternative treatment for constipation. ( Fu, A, 2005) |
| "On the second day, signs of Ogilvie's syndrome characterized by severe tenderness, distension and pain in the abdomen were seen." | 1.33 | Amitraz: an unusual aetiology of Ogilvie's syndrome. ( Aslan, S; Aydinli, B; Bilge, F; Erdem, AF; Katirci, Y; Ocak, T; Uzkeser, M, 2005) |
| "Ogilvie's Syndrome is an infrequent complication of lumbar disc surgery, characterized by acute paralytic ileum as a result of acute colonic dilatation without mechanical obstruction." | 1.31 | [Ogilvie's syndrome. A report of 3 cases]. ( Mosquera-Betancourt, G; Varela Hernández, A; Vega-Basulto, SD, 2002) |
| "Acute colonic pseudoobstruction (ACPO) most commonly develops after surgery, with narcotic administration, or in association with severe illness." | 1.31 | Assessment of predictors of response to neostigmine for acute colonic pseudo-obstruction. ( Baron, TH; Harewood, GC; Loftus, CG, 2002) |
| " NSM is a simple, safe, and effective treatment for ACPO and based on result comparison of this study and previous studies both bolus and slow infusion dosing practices of NSM are effective." | 1.31 | Retrospective study of neostigmine for the treatment of acute colonic pseudo-obstruction. ( Abeyta, BJ; Albrecht, RM; Schermer, CR, 2001) |
| "Neostigmine was recently shown to be effective and safe for the treatment of Ogilvie's syndrome." | 1.31 | [Neostigmine treatment of acute pseudo-obstruction of colon (Ogilvie syndrome)]. ( Klaver, NS; Koornstra, JJ; Limburg, AJ; ter Maaten, JC; van der Jagt, EJ; van der Werf, TS, 2001) |
| "Acute colonic pseudo-obstruction (Ogilvie's syndrome) is characterized by abdominal distention and massive colonic dilatation without any mechanical cause of obstruction." | 1.31 | Ogilvie's syndrome after cervical discectomy. ( Baykal, S; Cakir, E; Cinel, A; Kuzeyli, K; Usul, H, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (13.48) | 18.2507 |
| 2000's | 41 (46.07) | 29.6817 |
| 2010's | 28 (31.46) | 24.3611 |
| 2020's | 8 (8.99) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, S | 1 |
| Sharma, S | 1 |
| Jadbabaie, F | 1 |
| Liu, G | 1 |
| Hrabe, J | 1 |
| Sanchez, R | 1 |
| Williamson, S | 1 |
| Muller, A | 1 |
| Butts, CA | 1 |
| Geng, TA | 1 |
| Ong, AW | 1 |
| Sen, A | 1 |
| Chokshi, R | 1 |
| Naveed, M | 1 |
| Jamil, LH | 1 |
| Fujii-Lau, LL | 1 |
| Al-Haddad, M | 1 |
| Buxbaum, JL | 1 |
| Fishman, DS | 1 |
| Jue, TL | 1 |
| Law, JK | 1 |
| Lee, JK | 1 |
| Qumseya, BJ | 1 |
| Sawhney, MS | 1 |
| Thosani, N | 1 |
| Storm, AC | 1 |
| Calderwood, AH | 1 |
| Khashab, MA | 1 |
| Wani, SB | 1 |
| Bell, CM | 1 |
| Procter, LD | 1 |
| Parli, SE | 1 |
| Alavi, K | 1 |
| Poylin, V | 1 |
| Davids, JS | 1 |
| Patel, SV | 1 |
| Felder, S | 1 |
| Valente, MA | 1 |
| Paquette, IM | 1 |
| Feingold, DL | 2 |
| Kram, B | 1 |
| Greenland, M | 1 |
| Grant, M | 1 |
| Campbell, ME | 1 |
| Wells, C | 1 |
| Sommer, C | 1 |
| Haj, M | 2 |
| Rockey, DC | 1 |
| Smedley, LW | 1 |
| Foster, DB | 1 |
| Barthol, CA | 1 |
| Hall, R | 1 |
| Gutierrez, GC | 1 |
| İlban, Ö | 1 |
| Çiçekçi, F | 1 |
| Çelik, JB | 1 |
| Baş, MA | 1 |
| Duman, A | 1 |
| Frankel, A | 1 |
| Gillespie, C | 1 |
| Lu, CT | 1 |
| Hewett, P | 1 |
| Wattchow, D | 1 |
| Lang, CL | 1 |
| Haveman, MC | 1 |
| Achiam, M | 1 |
| Ertberg, P | 1 |
| Vilandt, J | 1 |
| Bødker, B | 1 |
| Wiersema, US | 1 |
| Bruno, MJ | 1 |
| Tjwa, ET | 1 |
| Hooten, KG | 1 |
| Oliveria, SF | 1 |
| Larson, SD | 1 |
| Pincus, DW | 1 |
| Pereira, P | 1 |
| Djeudji, F | 1 |
| Leduc, P | 1 |
| Fanget, F | 1 |
| Barth, X | 1 |
| Reeves, M | 1 |
| Frizelle, F | 1 |
| Wakeman, C | 1 |
| Parker, C | 1 |
| Keller, J | 1 |
| Layer, P | 1 |
| Pyo, JH | 1 |
| Min, YW | 1 |
| Rhee, PL | 1 |
| Dodds, MM | 1 |
| Frazer, CD | 1 |
| Lipman, J | 1 |
| Reade, M | 1 |
| Vogel, JD | 1 |
| Stewart, DB | 1 |
| Turner, JS | 1 |
| Boutros, M | 1 |
| Chun, J | 1 |
| Steele, SR | 1 |
| Peker, KD | 1 |
| Cikot, M | 1 |
| Bozkurt, MA | 1 |
| Ilhan, B | 1 |
| Kankaya, B | 1 |
| Binboga, S | 1 |
| Seyit, H | 1 |
| Alis, H | 1 |
| Hinkson, L | 1 |
| Faensen, AL | 1 |
| Armbrust, R | 1 |
| Henrich, W | 1 |
| Januszewski, J | 1 |
| Keem, SK | 1 |
| Smith, W | 1 |
| Beckman, JM | 1 |
| Kanter, AS | 1 |
| Oskuian, RJ | 1 |
| Taylor, W | 1 |
| Uribe, JS | 1 |
| Khan, MW | 1 |
| Ghauri, SK | 1 |
| Shamim, S | 1 |
| Khosla, A | 1 |
| Ponsky, TA | 1 |
| Delgado-Aros, S | 1 |
| Ilzarbe Sánchez, L | 1 |
| De Giorgio, R | 2 |
| Knowles, CH | 1 |
| Durai, R | 1 |
| Ozkurt, H | 1 |
| Yilmaz, F | 1 |
| Bas, N | 1 |
| Coskun, H | 1 |
| Basak, M | 1 |
| de Bruin, GJ | 1 |
| Bac, DJ | 1 |
| van Puijenbroek, EP | 1 |
| van der Klooster, JM | 1 |
| Descloux, A | 1 |
| Forberger, J | 1 |
| Metzger, U | 1 |
| Dejou-Bouillet, L | 1 |
| Bourdel, N | 1 |
| Slim, K | 1 |
| Vernis, L | 1 |
| Bazin, JE | 1 |
| Bonnin, M | 1 |
| Rabischong, B | 1 |
| Tran, X | 1 |
| Mage, G | 1 |
| Canis, M | 1 |
| White, L | 1 |
| Sandhu, G | 1 |
| Jessop, M | 1 |
| Choo, K | 1 |
| Little, M | 1 |
| Maher, L | 1 |
| Young, PJ | 1 |
| Elsner, JL | 1 |
| Smith, JM | 1 |
| Ensor, CR | 1 |
| Xie, H | 1 |
| Peereboom, DM | 1 |
| Johnson, LM | 1 |
| Spraker, HL | 1 |
| Coleman, JL | 1 |
| Baker, JN | 1 |
| Kayani, B | 1 |
| Spalding, DR | 1 |
| Jiao, LR | 1 |
| Habib, NA | 1 |
| Zacharakis, E | 1 |
| Tsirline, VB | 1 |
| Zemlyak, AY | 1 |
| Avery, MJ | 1 |
| Colavita, PD | 1 |
| Christmas, AB | 1 |
| Heniford, BT | 1 |
| Sing, RF | 1 |
| Vega-Basulto, SD | 1 |
| Mosquera-Betancourt, G | 1 |
| Varela Hernández, A | 1 |
| Gmora, S | 1 |
| Poenaru, D | 1 |
| Tsai, E | 1 |
| Loftus, CG | 1 |
| Harewood, GC | 1 |
| Baron, TH | 1 |
| Saunders, MD | 6 |
| Kimmey, MB | 3 |
| Calvet, X | 1 |
| Martinez, JM | 1 |
| Martinez, M | 1 |
| Ould-Ahmed, M | 1 |
| de Saint-Martin, L | 1 |
| Ansart, S | 1 |
| Renault, A | 1 |
| Boles, JM | 1 |
| Maeda, N | 1 |
| Murai, M | 1 |
| Nakazawa, A | 1 |
| Suzuki, O | 1 |
| Mizuno, Y | 1 |
| Yamamoto, Y | 1 |
| Shimizu, K | 1 |
| Hibi, T | 1 |
| Fu, A | 1 |
| Hsiao, E | 1 |
| Charles, R | 1 |
| Magid, C | 1 |
| Nivatpumin, P | 1 |
| Wiener, CM | 1 |
| Aslan, S | 1 |
| Bilge, F | 1 |
| Aydinli, B | 1 |
| Ocak, T | 1 |
| Uzkeser, M | 1 |
| Erdem, AF | 1 |
| Katirci, Y | 1 |
| Sgouros, SN | 1 |
| Vlachogiannakos, J | 1 |
| Vassiliadis, K | 1 |
| Bergele, C | 1 |
| Stefanidis, G | 1 |
| Nastos, H | 1 |
| Avgerinos, A | 1 |
| Mantides, A | 1 |
| Mehta, R | 1 |
| John, A | 1 |
| Nair, P | 1 |
| Raj, VV | 1 |
| Mustafa, CP | 1 |
| Suvarna, D | 1 |
| Balakrishnan, V | 1 |
| Cherta, I | 1 |
| Forné, M | 1 |
| Quintana, S | 1 |
| Garriga, MR | 1 |
| González de Molina, FJ | 1 |
| Lankarani-Fard, A | 1 |
| Castle, SC | 1 |
| Rausch, ME | 1 |
| Troiano, NH | 1 |
| Rosen, T | 1 |
| Kim, TS | 1 |
| Lee, JW | 1 |
| Kim, MJ | 1 |
| Park, YS | 1 |
| Lee, DH | 1 |
| Chung, NG | 1 |
| Cho, B | 1 |
| Lee, S | 1 |
| Kim, HK | 1 |
| McNamara, R | 1 |
| Mihalakis, MJ | 1 |
| Stephenson, BM | 4 |
| Morgan, AR | 3 |
| Salaman, JR | 2 |
| Wheeler, MH | 3 |
| Drake, N | 1 |
| Vantrappen, G | 1 |
| St John, PH | 1 |
| Radcliffe, AG | 1 |
| Turégano-Fuentes, F | 1 |
| Muñoz-Jiménez, F | 1 |
| Del Valle-Hernández, E | 1 |
| Pérez-Díaz, D | 1 |
| Calvo-Serrano, M | 1 |
| De Tomás, J | 1 |
| De Fuenmayor, ML | 1 |
| Quintans-Rodríguez, A | 1 |
| Ponec, RJ | 1 |
| Laine, L | 1 |
| Daaboul, B | 1 |
| Eaker, EY | 2 |
| Abbasakoor, F | 1 |
| Evans, A | 1 |
| Vavilala, MS | 1 |
| Lam, AM | 1 |
| Pierach, CA | 1 |
| Amaro, R | 1 |
| Rogers, AI | 1 |
| Hasler, WL | 1 |
| Paran, H | 1 |
| Silverberg, D | 1 |
| Mayo, A | 1 |
| Shwartz, I | 1 |
| Neufeld, D | 1 |
| Freund, U | 1 |
| Trevisani, GT | 1 |
| Hyman, NH | 1 |
| Church, JM | 1 |
| Fink, S | 1 |
| Chaudhuri, TK | 1 |
| Fielding, LP | 1 |
| Shultz, SM | 1 |
| Abeyta, BJ | 1 |
| Albrecht, RM | 1 |
| Schermer, CR | 1 |
| Koornstra, JJ | 1 |
| Klaver, NS | 1 |
| ter Maaten, JC | 1 |
| Limburg, AJ | 1 |
| van der Jagt, EJ | 1 |
| van der Werf, TS | 1 |
| Loffeld, RJ | 1 |
| van der Spoel, JI | 1 |
| Oudemans-van Straaten, HM | 1 |
| Stoutenbeek, CP | 1 |
| Bosman, RJ | 1 |
| Zandstra, DF | 1 |
| Barbara, G | 1 |
| Stanghellini, V | 1 |
| Tonini, M | 1 |
| Vasina, V | 1 |
| Cola, B | 1 |
| Corinaldesi, R | 1 |
| Biagi, G | 1 |
| De Ponti, F | 1 |
| Cakir, E | 1 |
| Baykal, S | 1 |
| Usul, H | 1 |
| Kuzeyli, K | 1 |
| Cinel, A | 1 |
| Breccia, M | 1 |
| Girmenia, C | 1 |
| Mecarocci, S | 1 |
| Cartoni, C | 1 |
| Carmosino, I | 1 |
| Tafuri, A | 1 |
| Alimena, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluating the Safety and Efficacy of Different Routes of Neostigmine Administration for Acute Colonic Pseudo Obstruction: a Prospective Randomized Trial[NCT04951726] | Phase 4 | 90 participants (Anticipated) | Interventional | 2022-02-04 | Recruiting | ||
| A New Approach of Neostigmine in Unavoidable Post Operative Ileus After Surgery[NCT00676377] | Phase 4 | 3 participants (Actual) | Interventional | 2007-08-31 | Completed | ||
| The Curative Effect and Security of Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension[NCT02543658] | Phase 2 | 80 participants (Actual) | Interventional | 2015-09-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Days in hospital within 6 months after randomisation (NCT02543658)
Timeframe: From randomisation to 6 months
| Intervention | days (Median) |
|---|---|
| Neostigmine | 20 |
| Conservative Treatment | 19 |
Days in ICU within 6 months after randomisation (NCT02543658)
Timeframe: From randomisation to 6 months
| Intervention | days (Median) |
|---|---|
| Neostigmine | 12 |
| Conservative Treatment | 12 |
Death during from randomization to 90 days after onset. (NCT02543658)
Timeframe: From randomization to 90 days after onset.
| Intervention | Participants (Count of Participants) |
|---|---|
| Neostigmine | 10 |
| Conservative Treatment | 11 |
Medical expenses within 6 months after randomisation (NCT02543658)
Timeframe: From randomisation to 6 months
| Intervention | thousand(RMB) (Median) |
|---|---|
| Neostigmine | 95.3 |
| Conservative Treatment | 102.3 |
Abdominal compartment syndrome is defined as a sustained IAP>20 mmHg (with or without an APP<60 mmHg) that is associated with new organ dysfunction/failure (NCT02543658)
Timeframe: From randomization to discharge or death, assessed up to 4 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Neostigmine | 2 |
| Conservative Treatment | 4 |
Incidence of organ failure from randomization to discharge or death, assessed up to 3 months (NCT02543658)
Timeframe: From randomization to discharge or death, assessed up to 3 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Neostigmine | 12 |
| Conservative Treatment | 16 |
Due to that neostigmine has an inhibitory effect on the cardiovascular system, new-onset cardiovascular failure after grouping is considered as a possible adverse event related to neostigmine.Cardiovascular failure was defined as circulatory systolic blood pressure <90 mm Hg, despite adequate fluid resuscitation, or need for inotropic catecholamine support (NCT02543658)
Timeframe: From randomization to 7 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Neostigmine | 8 |
| Conservative Treatment | 4 |
IAP rebound ≥ 5mmHg or increase ≥ 20mmHg within 1-7 days after grouping (NCT02543658)
Timeframe: From randomization to 7 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Neostigmine | 4 |
| Conservative Treatment | 8 |
From date of randomization to enteral nutrition, assessed up to 30 days (NCT02543658)
Timeframe: Start time of enteral nutrition after randomization, assessed up to 30 days
| Intervention | days (Median) |
|---|---|
| Neostigmine | 3 |
| Conservative Treatment | 4 |
Monitor the intra-abdominal pressure within 1 to 7 days after randomization, and calculate the percent change compared with that before randomization (NCT02543658)
Timeframe: From randomization to 7 days after treatment,Measured IAP every 6 hours
| Intervention | percent change of IAP (Median) | |
|---|---|---|
| percent change of IAP at 24 hours | percent change of IAP at 7 days | |
| Conservative Treatment | -5.4 | -20.0 |
| Neostigmine | -18.7 | -27.2 |
After randomization, the change of stool volume (ML) was calculated every 24 hours.For example, the amount of stool volume decreased or increased in 24 hours after grouping compared to before grouping. (NCT02543658)
Timeframe: From randomization to 7 days
| Intervention | ml/day (Median) | |
|---|---|---|
| The change of stool volume at 24 hours | The change of stool volume at 7th day | |
| Conservative Treatment | 60 | 370 |
| Neostigmine | 870 | 1025 |
17 reviews available for neostigmine and Colonic Pseudo-Obstruction
| Article | Year |
|---|---|
Update on the Diagnosis and Management of Acute Colonic Pseudo-obstruction (ACPO).
Topics: Acute Disease; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Endoscopy, Gastrointestinal; H | 2023 |
[Diagnosis and treatment of acute colonic pseudo-obstruction].
Topics: Colonic Pseudo-Obstruction; Colonoscopy; Critical Pathways; Humans; Neostigmine; Parasympathomimetic | 2013 |
Ogilvie's syndrome-acute colonic pseudo-obstruction.
Topics: Catheters, Indwelling; Colectomy; Colonic Pseudo-Obstruction; Colonoscopy; Evidence-Based Medicine; | 2015 |
[Acute colonic pseudo-obstruction: Ogilvie syndrome].
Topics: Colonic Pseudo-Obstruction; Contrast Media; Critical Care; Critical Illness; Decompression, Surgical | 2015 |
Acute colonic pseudo-obstruction.
Topics: Acute Disease; Cecostomy; Colonic Pseudo-Obstruction; Colonoscopy; Decompression, Surgical; Humans; | 2009 |
Colonic pseudo-obstruction.
Topics: Cecostomy; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Digestive System Surgical Procedur | 2009 |
Intravenous neostigmine for postoperative acute colonic pseudo-obstruction.
Topics: Bradycardia; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Humans; Infusions, Intravenous; | 2012 |
Does neostigmine improve time to resolution of symptoms in acute colonic pseudo-obstruction?
Topics: Acute Disease; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Humans; Neostigmine; Time Fact | 2012 |
Colonic pseudo-obstruction: the dilated colon in the ICU.
Topics: Acute Disease; Aged; Aged, 80 and over; Analgesics, Opioid; Cholinesterase Inhibitors; Colonic Pseud | 2003 |
[A case of chronic colonic pseudo-obstruction due to amyloidosis successfully treated with neostigmine].
Topics: Amyloidosis; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Female; Humans; Middle Aged; Neo | 2004 |
Acute colonic pseudoobstruction.
Topics: Acute Disease; Colonic Pseudo-Obstruction; Decompression, Surgical; Diagnosis, Differential; Endosco | 2004 |
Systematic review: acute colonic pseudo-obstruction.
Topics: Acute Disease; Colonic Pseudo-Obstruction; Humans; Neostigmine; Parasympathomimetics; Patient Care M | 2005 |
Acute colonic pseudo-obstruction.
Topics: Acute Disease; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Colonoscopy; Combined Modality | 2007 |
Acute colonic pseudo-obstruction.
Topics: Acute Disease; Colonic Pseudo-Obstruction; Colonoscopy; Decompression, Surgical; Humans; Neostigmine | 2007 |
Acute colonic pseudo-obstruction: rapid correction with neostigmine in the emergency department.
Topics: Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Emergency Service, Hospital; Humans; Male; Mi | 2008 |
Update on acute colonic pseudo-obstruction.
Topics: Acute Disease; Colonic Pseudo-Obstruction; Combined Modality Therapy; Humans; Neostigmine; Parasympa | 2001 |
Review article: the pharmacological treatment of acute colonic pseudo-obstruction.
Topics: Acute Disease; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Gastrointestinal Motility; Hum | 2001 |
6 trials available for neostigmine and Colonic Pseudo-Obstruction
| Article | Year |
|---|---|
Colonoscopic decompression should be used before neostigmine in the treatment of Ogilvie's syndrome.
Topics: Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Colonoscopy; Decompression, Surgical; Female; | 2017 |
Effect of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudo obstruction after resolution of colonic dilation: a prospective, randomised, placebo controlled trial.
Topics: Acute Disease; Aged; Cathartics; Colon; Colonic Pseudo-Obstruction; Colonoscopy; Decompression, Surg | 2006 |
Ogilvie's syndrome: a new approach to an old problem.
Topics: Adult; Aged; Aged, 80 and over; Colonic Pseudo-Obstruction; Contrast Media; Dose-Response Relationsh | 1995 |
Neostigmine for the treatment of acute colonic pseudo-obstruction.
Topics: Abdominal Pain; Acute Disease; Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Colonic Ps | 1999 |
Neostigmine for the treatment of acute colonic pseudo-obstruction.
Topics: Abdominal Pain; Acute Disease; Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Colonic Ps | 1999 |
Neostigmine for the treatment of acute colonic pseudo-obstruction.
Topics: Abdominal Pain; Acute Disease; Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Colonic Ps | 1999 |
Neostigmine for the treatment of acute colonic pseudo-obstruction.
Topics: Abdominal Pain; Acute Disease; Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Colonic Ps | 1999 |
Neostigmine for the treatment of acute colonic pseudo-obstruction.
Topics: Abdominal Pain; Acute Disease; Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Colonic Ps | 1999 |
Neostigmine for the treatment of acute colonic pseudo-obstruction.
Topics: Abdominal Pain; Acute Disease; Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Colonic Ps | 1999 |
Neostigmine for the treatment of acute colonic pseudo-obstruction.
Topics: Abdominal Pain; Acute Disease; Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Colonic Ps | 1999 |
Neostigmine for the treatment of acute colonic pseudo-obstruction.
Topics: Abdominal Pain; Acute Disease; Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Colonic Ps | 1999 |
Neostigmine for the treatment of acute colonic pseudo-obstruction.
Topics: Abdominal Pain; Acute Disease; Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Colonic Ps | 1999 |
Neostigmine infusion: new standard of care for acute colonic pseudo-obstruction?
Topics: Acute Disease; Colonic Pseudo-Obstruction; Double-Blind Method; Humans; Infant; Infusions, Intraveno | 2000 |
Neostigmine resolves critical illness-related colonic ileus in intensive care patients with multiple organ failure--a prospective, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; APACHE; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Criti | 2001 |
66 other studies available for neostigmine and Colonic Pseudo-Obstruction
| Article | Year |
|---|---|
Management of acute colonic pseudo-obstruction in a neutropenic patient.
Topics: Aged; Colonic Pseudo-Obstruction; Colonoscopes; Humans; Male; Neostigmine; Neutropenia | 2022 |
Colostomy as a definitive treatment in an ALS patient with acute colonic Pseudo-obstruction refractory to medical management, a case report.
Topics: Acute Disease; Adult; Amyotrophic Lateral Sclerosis; Colonic Pseudo-Obstruction; Colostomy; Dioctyl | 2022 |
Acute Colonic Pseudo-obstruction: Colonoscopy Versus Neostigmine First?
Topics: Acute Disease; Colonic Pseudo-Obstruction; Colonoscopy; Humans; Neostigmine; Retrospective Studies; | 2023 |
American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the management of acute colonic pseudo-obstruction and colonic volvulus.
Topics: Acute Disease; Cecum; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Colonoscopy; Colostomy; | 2020 |
Asystole Following Concomitant Intravenous Administration of Neostigmine and Dexmedetomidine in a Patient With Acute Colonic Pseudo-Obstruction.
Topics: Acute Disease; Bradycardia; Colonic Pseudo-Obstruction; Dexmedetomidine; Heart Arrest; Humans; Infus | 2022 |
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colonic Volvulus and Acute Colonic Pseudo-Obstruction.
Topics: Acute Disease; Cecal Diseases; Cholinesterase Inhibitors; Colectomy; Colon; Colonic Pseudo-Obstructi | 2021 |
Efficacy and Safety of Subcutaneous Neostigmine for Ileus, Acute Colonic Pseudo-obstruction, or Refractory Constipation.
Topics: Acute Disease; Adult; Aged; Bradycardia; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Cons | 2018 |
Ogilvie's syndrome: management and outcomes.
Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Colonoscopy; Comorbi | 2018 |
Safety and Efficacy of Intermittent Bolus and Continuous Infusion Neostigmine for Acute Colonic Pseudo-Obstruction.
Topics: Acute Disease; Adult; Aged; Bradycardia; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Defe | 2020 |
Neostigmine treatment protocols applied in acute colonic pseudo-obstruction disease: A retrospective comparative study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Clinical Protocols; Coloni | 2019 |
Subcutaneous neostigmine appears safe and effective for acute colonic pseudo-obstruction (Ogilvie's syndrome).
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Colonic Pseudo-Obstruction; Female; Humans; Infusions | 2019 |
[Successful conservative treatment of coecal perforation in a patient with Ogilvie's syndrome].
Topics: Adult; Anti-Bacterial Agents; Cecal Diseases; Cesarean Section; Colonic Pseudo-Obstruction; Female; | 2013 |
On colonoscopy in acute colonic pseudo obstruction.
Topics: Acute Disease; Administration, Intravenous; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; C | 2013 |
Ogilvie's syndrome after pediatric spinal deformity surgery: successful treatment with neostigmine.
Topics: Adolescent; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Female; Humans; Injections, Intra | 2014 |
Acute colonic pseudo-obstruction in pregnancy.
Topics: Abdominal Pain; Acute Disease; Adult; Anti-Bacterial Agents; Cesarean Section; Colonic Pseudo-Obstru | 2015 |
Effective and Safe Use of Neostigmine in Treatment of Acute Kidney Injury Associated with Colonic Pseudo-obstruction after Cardiac Surgery.
Topics: Acute Kidney Injury; Aged; Cardiac Surgical Procedures; Colonic Pseudo-Obstruction; Creatinine; Huma | 2016 |
Use of neostigmine for acute colonic pseudo-obstruction in a patient receiving dexmedetomidine.
Topics: Acute Disease; Analgesics, Non-Narcotic; Bradycardia; Cholinesterase Inhibitors; Colonic Pseudo-Obst | 2016 |
Clinical Practice Guidelines for Colon Volvulus and Acute Colonic Pseudo-Obstruction.
Topics: Acute Disease; Cholinesterase Inhibitors; Colectomy; Colonic Pseudo-Obstruction; Colonoscopy; Colost | 2016 |
The O-Sign: early recognition of O-shaped abdominal distension avoids drastic surgical intervention in Ogilvie Syndrome after caesarean section.
Topics: Adult; Cesarean Section; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Colonoscopy; Drainag | 2016 |
The Potentially Fatal Ogilvie's Syndrome in Lateral Transpsoas Access Surgery: A Multi-Institutional Experience with 2930 Patients.
Topics: Aged; Aged, 80 and over; Cecum; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Female; Human | 2017 |
Ogilvie's Syndrome.
Topics: Abdominal Pain; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Female; Humans; Middle Aged; | 2016 |
Acute colonic pseudoobstruction in a child with sickle cell disease treated with neostigmine.
Topics: Abdominal Pain; Acute Disease; Anemia, Sickle Cell; Blood Transfusion; Child, Preschool; Cholinester | 2008 |
[Gastrointestinal endoscopy. Is decompressive endoscopy indicated as the first-line measure in patients with acute colonic pseudoobstruction, also known as Ogilvie syndrome?].
Topics: Acute Disease; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Decompression, Surgical; Doubl | 2008 |
Acute colonic pseudo-obstruction (Ogilvie's syndrome): radiologic diagnosis and medical treatment with neostigmine. Report of 4 cases.
Topics: Aged; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Female; Humans; Male; Middle Aged; Neos | 2009 |
[Ogilvie Syndrome induced by clozapine].
Topics: Adult; Antipsychotic Agents; Clozapine; Colonic Pseudo-Obstruction; Gastrointestinal Transit; Humans | 2009 |
[What is your diagnosis? Acute colonic pseudoobstruction (Ogilvie syndrome) in hypothyreosis].
Topics: Acute Disease; Aged, 80 and over; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Diagnosis, | 2010 |
[Ogilvie's syndrome after cesarean section: a case report].
Topics: Adult; Algorithms; Cesarean Section; Colonic Pseudo-Obstruction; Colonoscopy; Female; Humans; Neosti | 2010 |
Continuous neostigmine infusion versus bolus neostigmine in refractory Ogilvie syndrome.
Topics: Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Humans; Infusions, Intravenous; Injections, I | 2011 |
Acute colonic pseudo-obstruction in paediatric oncology patients.
Topics: Antineoplastic Agents; Child; Colonic Pseudo-Obstruction; Constipation; Female; Humans; Male; Neosti | 2010 |
Cardiac arrest complicating neostigmine use for bowel opening in a critically ill patient.
Topics: Adolescent; Bradycardia; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Critical Illness; Fe | 2011 |
Ogilvie's syndrome during chemotherapy with high-dose methotrexate for primary CNS lymphoma.
Topics: Abdominal Pain; Aged; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Colon; Colo | 2012 |
An unusual case of Ogilvie syndrome in a pediatric oncology patient receiving palliative care after failed treatment with neostigmine.
Topics: Adolescent; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Colonoscopy; Diagnosis, Different | 2012 |
Colonoscopy is superior to neostigmine in the treatment of Ogilvie's syndrome.
Topics: Cecum; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Colonoscopy; Combined Modality Therapy | 2012 |
[Ogilvie's syndrome. A report of 3 cases].
Topics: Adult; Cecal Diseases; Cholinesterase Inhibitors; Colonic Diseases, Functional; Colonic Pseudo-Obstr | 2002 |
Neostigmine for the treatment of pediatric acute colonic pseudo-obstruction.
Topics: Child, Preschool; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Humans; Male; Neostigmine; | 2002 |
Assessment of predictors of response to neostigmine for acute colonic pseudo-obstruction.
Topics: Acute Disease; Aged; Aging; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Female; Forecasti | 2002 |
Repeated neostigmine dosage as palliative treatment for chronic colonic pseudo-obstruction in a patient with autonomic paraneoplastic neuropathy.
Topics: Autonomic Nervous System Diseases; Chronic Disease; Colonic Pseudo-Obstruction; Humans; Male; Middle | 2003 |
[Acute colonic pseudo-obstruction (Ogilvie's syndrome) in pneumococcal meningo-encephalitis treated with neostigmine].
Topics: Aged; Colonic Pseudo-Obstruction; Critical Care; Humans; Male; Meningitis, Pneumococcal; Meningoence | 2003 |
Neostigmine: an alternative treatment for constipation.
Topics: Aged; Amyotrophic Lateral Sclerosis; Colonic Pseudo-Obstruction; Constipation; Critical Illness; Fem | 2005 |
An unusual development.
Topics: Adult; Anemia, Sickle Cell; Colon; Colonic Pseudo-Obstruction; Comorbidity; Dilatation, Pathologic; | 2005 |
Amitraz: an unusual aetiology of Ogilvie's syndrome.
Topics: Adult; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Female; Humans; Insecticides; Neostigm | 2005 |
Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo-obstruction: a prospective study.
Topics: Acute Disease; Adolescent; Adult; Aged; Colonic Pseudo-Obstruction; Colonoscopy; Female; Follow-Up S | 2006 |
Prolonged treatment with neostigmine for resolution of acute colonic pseudo-obstruction.
Topics: Acute Disease; Colonic Pseudo-Obstruction; Humans; Neostigmine; Parasympathomimetics; Treatment Outc | 2006 |
Postoperative delirium and Ogilvie's syndrome resolving with neostigmine.
Topics: Aged; Arthroplasty, Replacement, Knee; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Deliri | 2006 |
Use of neostigmine to relieve a suspected colonic pseudoobstruction in pregnancy.
Topics: Abdominal Pain; Adult; Colectomy; Colonic Pseudo-Obstruction; Diagnosis, Differential; Female; Human | 2007 |
Acute colonic pseudo-obstruction in postchemotherapy complication of brain tumor treated with neostigmine.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cecum; Child; Colon; | 2007 |
Parasympathomimetic decompression of acute colonic pseudo-obstruction.
Topics: Adult; Aged; Aged, 80 and over; Colonic Pseudo-Obstruction; Female; Humans; Male; Middle Aged; Neost | 1993 |
Acute colonic pseudo-obstruction.
Topics: Acute Disease; Cisapride; Colonic Pseudo-Obstruction; Erythromycin; Guanethidine; Humans; Neostigmin | 1993 |
Parasympathomimetics in Ogilvie's syndrome.
Topics: Colonic Pseudo-Obstruction; Humans; Neostigmine | 1994 |
Contraindication for the use of neostigmine in colonic pseudo-obstruction.
Topics: Aged; Aged, 80 and over; Colonic Pseudo-Obstruction; Contraindications; Duodenal Ulcer; Humans; Male | 1997 |
Early resolution of Ogilvie's syndrome with intravenous neostigmine: a simple, effective treatment.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Colonic Pseudo-Obstruction; Contraindications; Female | 1997 |
Management of acute colonic pseudo-obstruction.
Topics: Acute Disease; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Humans; Intestinal Perforation | 1999 |
Successful decompression of colonic pseudo-obstruction with neostigmine.
Topics: Cholinesterase Inhibitors; Colonic Diseases; Colonic Pseudo-Obstruction; Diabetes Mellitus, Type 2; | 1999 |
Neostigmine for acute colonic pseudo-obstruction.
Topics: Acute Disease; Bradycardia; Colonic Pseudo-Obstruction; Contrast Media; Diagnostic Errors; Enema; Gl | 1999 |
Neostigmine for acute colonic pseudo-obstruction.
Topics: Acute Disease; Bradycardia; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Glycopyrrolate; H | 1999 |
Neostigmine for acute colonic pseudo-obstruction.
Topics: Clinical Trials as Topic; Colonic Pseudo-Obstruction; Humans; Neostigmine; Patient Selection; Time F | 1999 |
Neostigmine for acute colonic pseudo-obstruction: new use for an old drug?
Topics: Acute Disease; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Colonoscopy; Humans; Neostigmi | 2000 |
Treatment of acute colonic pseudo-obstruction with neostigmine.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Colonic Pseudo-Obstruction; Female; Humans; Male; Mid | 2000 |
Neostigmine: safe and effective treatment for acute colonic pseudo-obstruction.
Topics: Acute Disease; Aged; Aged, 80 and over; Colonic Pseudo-Obstruction; Female; Humans; Infusions, Intra | 2000 |
Neostigmine treatment for acute colonic pseudo-obstruction.
Topics: Colon; Colonic Pseudo-Obstruction; Gastrointestinal Transit; Humans; Muscle, Smooth; Neostigmine; Pa | 2000 |
Treatment of acute colonic pseudo-obstruction.
Topics: Colonic Pseudo-Obstruction; Humans; Information Storage and Retrieval; MEDLINE; Neostigmine; Parasym | 2001 |
Retrospective study of neostigmine for the treatment of acute colonic pseudo-obstruction.
Topics: Acute Disease; Aged; Aged, 80 and over; Algorithms; Bradycardia; Colonic Pseudo-Obstruction; Contrai | 2001 |
[Neostigmine treatment of acute pseudo-obstruction of colon (Ogilvie syndrome)].
Topics: Aged; Colonic Pseudo-Obstruction; Humans; Infusions, Intravenous; Intestinal Perforation; Male; Neos | 2001 |
[Neostigmine for the treatment of acute pseudo-obstruction of the colon (Ogilvie syndrome)].
Topics: Acute Disease; Colonic Pseudo-Obstruction; Contraindications; Diagnosis, Differential; Humans; Intes | 2001 |
Ogilvie's syndrome after cervical discectomy.
Topics: Adult; Cervical Vertebrae; Colonic Pseudo-Obstruction; Diskectomy; Female; Humans; Neostigmine; Para | 2001 |
Ogilvie's syndrome in acute myeloid leukemia: pharmacological approach with neostigmine.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cholinesterase I | 2001 |